1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole, 97%, 250mg

Arsenazo III, min.85%, pa, 5 g, emballage en verre

7-Chlorothieno[3,2-b]pyridine oxalate, 98%, 250mg

3-{4-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl}pyridine, 97%, 250mg

tert-Butyl 7-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 5g

(5-(Benzyloxy)-1-(tert-butoxycarbonyl)-1H-indol-2-yl)boronic acid, 98.0%, 1g

(2-Methyl-thiazol-4-yl)-acetic acid ethyl ester, 95.0%, 5g

1-(2,2-difluoroethyl)-3-nitro-1H-pyrazole, 10g

1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-(phenylsulfonyl)-, 95+%, 5g

(2S,3R,4S,5S,6R)-2-((5-Bromo-4-chloro-1H-indol-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 1g

Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate, 95.0%, 1g

Ethyl 7-methyl-1H-indole-2-carboxylate, 97%, 1g

1-(4-Chloro-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, 97.0%, 10g